JY
HOOK

Jeff Yass’s HOOKIPA Pharma HOOK Stock Holding History

Jeff Yass’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,550
Closed -$15K – 12416
2024
Q2 		$15K Buy
+2,550
New +$20.2K ﹤0.01% 11716
2022
Q4 		– Sell
-2,780
Closed -$37K – 12938
2022
Q3 		$37K Buy
2,780
+160
+6% +$2.46K ﹤0.01% 12365
2022
Q2 		$43K Sell
2,620
-3,380
-56% -$56K ﹤0.01% 12054
2022
Q1 		$137K Buy
+6,000
New +$108K ﹤0.01% 11634
2021
Q4 		– Sell
-4,980
Closed -$293K – 13436
2021
Q3 		$293K Sell
4,980
-2,730
-35% -$198K ﹤0.01% 10657
2021
Q2 		$706K Buy
7,710
+4,700
+156% +$627K ﹤0.01% 8723
2021
Q1 		$405K Sell
3,010
-4,720
-61% -$569K ﹤0.01% 9957
2020
Q4 		$857K Buy
7,730
+5,520
+250% +$596K ﹤0.01% 7068
2020
Q3 		$209K Buy
+2,210
New +$225K ﹤0.01% 9376

Other funds holding HOOK

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jeff Yass's HOOK Position: Q3 2025 in Review

Jeff Yass sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 37,265 shares — an estimated $46.8K sold.

Jeff Yass first reported a position in HOOK in Q3 2020 and held it in 13 quarters. The position peaked at $609K in Q2 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Jeff Yass reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Jeff Yass sold 37,265 HOOKIPA Pharma shares in Q3 2025, an estimated $46.8K.
  • Jeff Yass first reported a position in HOOKIPA Pharma in Q3 2020 and held it in 13 quarters.
  • Jeff Yass's HOOKIPA Pharma position peaked at $609K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.